Skip to main navigation Skip to search Skip to main content

Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1123-1125
Number of pages3
JournalLeukemia and Lymphoma
Volume56
Issue number4
DOIs
Publication statusPublished - 01-04-2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this